Project Grant HT9425261E143
Award Date 8/1/26
Completion Date 7/31/29
Dollars Obligated $302K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $1.645 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2028. The award funds research investigating bone fracture-induced joint bleeding and its role in posttraumatic osteoarthritis development. This research aligns with the DHA's mission...
- Federal Project Grant Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $650,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research on psychiatric aspects of post-traumatic epilepsy. The award, dated April 15, 2025, supports a three-year performance period through April 14, 2028, with performance conducted at Columbia's New York, NY location. This...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $1.6M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research investigating the role of Streptococcus in esophageal neoplasia, with research activities conducted at the institution's facilities in New York, NY. This three-year funded initiative falls within...
- Federal Grant Award Summary The University of Utah received a $695,255 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning August 1, 2026 and concluding July 31, 2029. The award supports research titled "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DOD-VHA Data, Patient Preferences and Health Economics." This project will generate evidence-based...
- The Defense Health Agency awarded a $1,316,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "ADVANCING WRN AS A PROMISING THERAPEUTIC TARGET FOR MSI-H CANCERS" to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York—Health Sciences Division a $218,055 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, with a completion date of July 31, 2028. The award funds research titled "Enhancing Early Detection of Pancreatic Cancer Using GPT-Embedded EHR Models: A Novel Approach for Improved Predictive Performance and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York a $2.8 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a pilot clinical trial of NL-CHCHD-001, a novel antisense oligonucleotide therapeutic for CHCHD10-associated amyotrophic lateral sclerosis (ALS). The award, effective June 1, 2026, through May 31, 2029, supports clinical investigation and translational...
- The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
- Federal Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $822,499 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with completion targeted for August 14, 2028. The award supports research investigating the role of methionine oxidation in cancer-associated cachexia, a condition characterized by progressive muscle and...